C. Mukhopadhyay et al. / Tetrahedron Letters 52 (2011) 4153–4157
4157
11. (a) Blatt, A. H.; Gross, N. J. Org. Chem. 1964, 29, 3306; (b) Kobayashi, S.; Ishitani,
H. Chem. Rev. 1999, 99, 1069; (c) Mannich, C.; Krosche, W. Arch. Pharm. 1912,
250, 674; (d) Mukhopadhyay, C.; Datta, A.; Butcher, R. J. Tetrahedron Lett. 2009,
50, 4246.
Acknowledgements
One of the authors (SR) thanks the Council of Scientific and
Industrial Research, New Delhi, for his fellowship (SRF). We thank
the CAS Instrumentation Facility, Department of Chemistry,
University of Calcutta for spectral data. We also acknowledge the
grant received from the UGC funded Major project, F. No.
37–398/2009 (SR) dated 11-01-2010.
12. General procedure for the synthesis of hexahydropyrimidines and its spiro
analogues.
A
mixture of b-keto ester (1 mmol), aniline (2 mmol),
formaldehyde (3 mmol, 37–41% aqueous solution) and a catalytic amount of
FeCl3 (5 mol %) in dichloromethane (5 mL) was stirred at room temperature for
the stipulated times mentioned in Tables 2 and 3. The progress of the reaction
was monitored by TLC. After the completion of the reaction, FeCl3 was removed
from the reaction mixture by filtration. The solvent was removed under
reduced pressure. The crude product mixture was then purified by silica gel
(60–120 mesh) column chromatography with 5% ethyl acetate in petroleum
ether (60–80 °C) as eluant. Spectral and analytical data of all the compounds in
Table 2–4 are given in the supplementary section. The spectral and analytical
data of one of each representative compounds is given here: 5-acetyl-1,3-
diphenyl-hexahydro-pyrimidine-5-carboxylic acid ethyl ester (4a): (Table 2, entry
1) brown viscous liquid, mmax (KBr)/cmÀ1 3029, 2983, 2923, 2842, 1719, 1596,
1499, 1451, 1382, 1295, 1229, 1136, 1021 and 933; 1H NMR (300 MHz, CDCl3)
dH: 7.35–7.25 (4H, m, ArH), 7.06 (4H, dd, J = 8.7 Hz and 0.9 Hz, ArH), 6.97–6.90
(2H, m, ArH), 4.51 (1H, d, J = 10.8 Hz, equatorial N–CH–N), 4.46 (1H, d, axial
N–CH–N), 4.01 (2H, q, J = 7.2 Hz, O–CH2), 3.90–3.81 (4H, m, 2Â N–CH2), 2.23
(3H, s, CH3-CO), 1.14 (3H, t, J = 7.2 Hz, COOCH2CH3); 13C NMR (75 MHz, CDCl3)
dC: 202.7 (C, CH3-CO–), 169.0 (C, COOEt), 149.3 (C, Caromat), 129.2 (CH, Caromat),
121.1 (CH, Caromat), 117.8 (CH, Caromat), 68.2 (N-CH2-N), 61.8 (CH2, COO-CH2),
60.0 (C, C5), 53.7 (CH2-N), 26.7 (CH3-CO), 13.8 (CH3, COOCH2CH3); Anal. calcd
for C21H24N2O: C: 71.57; H: 6.86; N: 7.95. Found: C: 71.33; H: 6.91; N: 7.84.
2-(2,4-Di-phenyl-2,4-diazaspiro-6-yl)-indane-1,3-dione (5a) (Table 3, entry 1)
Supplementary data
Supplementary data associated with this article can be found, in
References and notes
1. (a) Groszkowki, S.; Korzycka, L.; Bialasiewicz, W. Pol. J. Parmacol. Pharm. 1973,
25, 573. Chem. Abstr. 1974, 80, 116181r.; (b) Yi, L.; Xu, X. Beijing Shifan Daxue
Xuebao, Ziran Kexueban 1990, 2, 54.
2. Siddiqui, A. Q.; Merson-Davies, L.; Cullis, P. M. J. Chem. Soc., Perkin Trans I 1999,
3243.
3. Hrvath, D. J. Med. Chem. 1997, 40, 2412. and the references therein.
4. Bergeron, R. J.; Seligsohn, H. W. Bioorg. Chem. 1986, 14, 345.
5. (a) Finch, H.; Peterson, E. A.; Ballard, S. A. J. Am. Chem. Soc. 1952, 74, 2016; (b)
Evans, R. F. Aust. J. Chem. 1967, 20, 1643; (c) Jutz, C.; Kirschner, A. F.; Wagner,
R.-M. Chem. Ber. 1977, 110, 1259; (d) Perillo, I. A.; Garcia, M. B.; Bisceglia, J. A.;
Orelli, L. R. J. Heterocycl. Chem. 2002, 39, 655; (e) Katrizky, A. R.; Singh, S. K.; He,
H.-Y. J. Org. Chem. 2002, 67, 3115.
6. (a) Palko, M.; Dervarics, M.; Fülöp, F. ARKIVOC 2005, VI, 416; (b)
Chantrapromma, K.; McManis, J. S.; Ganem, B. Tetrahedron Lett. 1980, 21,
2475; (c) Chantrapromma, K.; Ganem, B. Tetrahedron Lett. 1981, 22, 23.
7. (a) Kambe, S.; Saito, K.; Hirose, M.; Sakurai, A.; Midorikawa, H. Synthesis 1984,
10, 860; (b) Beresnevicius, Z. J.; Mickevicius, V.; Rutkauskas, K.; Kantminiene, K.
Polish J. Chem. Technol. 2003, 5, 75.
mp: 122–124 °C (EtOAc), m
max (KBr)/cmÀ1 3022, 2930, 2872, 1704, 1594, 1497,
1450, 1373, 1296, 1223, 1024, 926 and 749; 1H NMR (300 MHz, CDCl3) dH:
7.95–7.91 (2H, m, ArH), 7.85–7.80 (2H, m, ArH), 7.29–7.23 (4H, m, ArH), 6.95
(4H, dd, J = 7.8 Hz and 0.9 Hz, ArH), 6.91–6.84 (2H, m, ArH), 4.89 (2H, s, N-CH2-
N), 3.71 (4H, s, N-CH2); 13C NMR (75 MHz, CDCl3) dC: 199.4 (C, CO), 149.1 (C,
C
C
aromat), 140.7 (C, Caromat), 135.9 (CH, Caromat), 129.2 (CH, Caromat), 123.7 (CH,
aromat), 120.0 (CH, Caromat), 116.4 (CH, Caromat), 66.2 (CH2, N-CH2-N), 54.8 (C,
spiro carbon), 50.9 (CH2, N-CH2); Anal. calcd for C24H20N2O2: C: 78.24; H: 5.47;
N: 7.60. Found: C: 78.54; H: 4.39; N: 7.52.
13. General Procedure for the synthesis of spiro piperidines. A mixture of dimedone
(1 mmol), aniline (1 mmol), formaldehyde (3 mmol, 37–41% aqueous solution)
and a catalytic amount of FeCl3 (5 mol %) in dichloromethane (5 mL) was
stirred at room temperature for the stipulated time mentioned in Table 4. The
progress of the reaction was monitored by TLC. After the completion of the
reaction FeCl3 was removed from the reaction mixture by filtration. The
solvent was removed under reduced pressure. The crude product mixture was
then purified directly by crystallization from ethylacetate.
8. Wei, H.-L.; Yan, Z.-Y.; Niu, Y.-N.; Li, G.-Q.; Liang, Y.-M. J. Org. Chem. 2007, 72,
8600.
9. (a)Multicomponent Reactions; Zhu, J., Bienayme, H., Eds.; WILEY-VCH GmbH &
Co: KGaA, Weinheim, 2005; (b) Chanda, A.; Fokin, V. V. Chem. Rev. 2009, 109,
725; (c) Tejedor, D.; Garcia-Tellado, F. Chem. Soc. Rev. 2007, 36, 484; (d) Cariou,
C. C. A.; Clarkson, G. J.; Shipman, M. J. Org. Chem. 2008, 73, 9762; (e) Kupchan, S.
M.; Komoda, Y.; Court, W. A.; Thomas, G. J.; Smith, R. M.; Karim, A.; Gilmore, C.
J.; Haltivanger, R. C.; Bryan, R. F. J. Am. Chem. Soc. 1972, 94, 1354; (f) Armstrong,
R. W.; Combs, A. P.; Tempest, P. A.; Brown, S. D.; Keating, T. A. Acc. Chem. Res.
1996, 29, 123; (g) Zhou, L.; Bohle, D. S.; Jiang, H. F.; Li, C. J. Synlett 2009, 937; (h)
Ren, G.; Zhang, J.; Duan, Z.; Cui, M.; Wu, Y. Aust. J. Chem. 2009, 62, 75; (i)
Mukhopadhyay, C.; Tapaswi, P. K.; Drew, M. G. B. Tetrahedron Lett. 2010, 51,
3944; (j) Kozlov, N. G.; Kadutskii, A. P. Tetrahedron Lett. 2008, 49, 4560.
10. Trost, B. M. Angew. Chem., Int. Ed. 1995, 34, 259.
The spectral and analytical data of one of the representative compounds is
given here: Tetramethyl-15-(4-methylphenyl)-15-azadispiro[5.1.5.3]hexadecane-
1,5,9,13-tetrone (6a) (Table 4, entry 1) mp: 196–198 °C (EtOAc), 1H NMR
(300 MHz, CDCl3) dH: 7.06 (2H, d, J = 8.1 Hz, ArH), 7.00 (2H, d, J = 8.1 Hz, ArH),
3.39 (4H, s, NCH2), 2.83 (4H, d, J = 13.5 Hz, COCH2), 2.64 (4H, d, COCH2), 2.48
(2H, s, CH2), 2.26 (3H, s, CH3), 1.00 (12H, s, CH3); 13C NMR (75 MHz, CDCl3) dC:
205.9, 149.5, 131.3, 129.6, 119.2, 65.8, 55.6, 51.2, 32.2, 30.7, 28.6, 28.3, 20.5;
Anal. calcd for C26H33NO4: C: 73.73; H: 7.85; N: 3.31. Found: C: 73.94; H: 7.79;
N: 3.22.